Navigation Links
Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results
Date:2/8/2010

ss="xn-money">$58.8 million versus total liabilities of $4.8 million on December 31, 2009. For the first six months of fiscal 2010, the Company generated $4.9 million in cash from operations versus $3.9 million for the same period in fiscal 2009.

    Business Development & Outlook
    -- On October 29, 2009, Tianyin announced the Sichuan Jiangchuan
       Pharmaceutical Co., Ltd. ("Jiangchuan") joint venture, which will focus
       on production of macrolide antibiotics, such as Azithromycin, one of
       the world's best-selling antibiotics. Jiangchuan holds a license from
       Chinese State Food and Drug Administration (SFDA) to produce macrolide
       antibiotics and a related business license from the Industry and
       Commerce Bureau and Tax department. Tianyin owns 77% of Jiangchuan and
       will utilize this as the foundation for a broader, longer term strategy
       to build a significant presence in the rapidly growing Chinese
       macrolide antibiotics market, while diversifying its revenue base of
       western pharmaceuticals. Construction on a new production facility in
       Xinjin Industry Development Area commenced January 8, 2010, with Phase
       I expected to operational by July, 2010 and Phase II to be operational
       by the second half of 2010, with total anticipated capital expenditures
       of $20 million. The Company anticipates significant revenue and
       earnings contributions from this initiative during fiscal 2011.
    -- On December 1, 2009, Tianyin received SFDA approvals to produce two
       generic products, including a Pediatric Fever and Cough Oral Liquid and
       an Antibacterial/Anti-inflammatory Capsule. The Pediatric Fever and
       Cough Oral Liquid is a generic prescription TCM that is used for
       respiratory tract infections and influenza in children to ef
'/>"/>
SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Tianyin Pharmaceutical Co., Inc. Reports Record Fiscal 2009 Financials With $7.9 Million in Net Income
2. Tianyin Pharmaceutical Co., Inc. to Host Fiscal 2009 Earnings Conference Call on Thursday, September 24, 2009 at 10:30 a.m. ET
3. Tianyin Pharmaceutical Co., Inc. Obtains GMP Certification for Its New Production Facility
4. Tianyin Pharmaceutical, Co. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 11 at 10:50 am ET
5. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Sanqi Tablets and Yinqiao Jiedu Tablets
6. Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders
7. Tianyin Pharmaceutical Co., Inc. Adopts New Sales Strategy for Azithromycin Dispersible Tablets
8. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Wednesday, February 18, 2009 at 8:45 a.m. EST
9. Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth
10. Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
11. Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... JH Technologies announces the ... Irvine. JH Technologies, a leader in sales and ... an expanded partnership with Leica Microsystems into the Southern ... analysis solutions will be featured at the grand opening ... showroom facility is located within the JH Technologies office’s ...
(Date:9/17/2014)... 17, 2014 Terracon Corporation has announced ... TerraPure tank . This addition to the company’s ... FDA-compliant linear polyethylene and available in 125 or 250 ... ships in two weeks or less. , The new ... found in Terracon’s existing TerraPure tank line – plus ...
(Date:9/17/2014)... 17, 2014 Alternative Fuels Americas, Inc. (AFAI) announced ... Special Purpose Vehicle in partnership with Jatro Greentech, Inc., a ... company. The SPV shall be called AFAI Jatro Green Ethiopia ... majority shareholder. The SPV shall pursue Jatropha planting and biofuels ... Ethiopia . "Although we have ...
(Date:9/17/2014)... RXi Pharmaceuticals Corporation (NASDAQ: ... developing and commercializing innovative therapies addressing major unmet ... has been granted a patent by the United ... delivery system for delivering its "original" RNAi compounds ... treatment of diseases with an inflammatory component. Potential ...
Breaking Biology Technology:JH Technologies displays newest microscope imaging technology at Southern California showroom grand opening 2JH Technologies displays newest microscope imaging technology at Southern California showroom grand opening 3Terracon Introduces Pre-Engineered TerraPure® Tank for Ultrapure Water Applications 2AFAI Signs Joint Venture Agreement With Jatro Greentech Inc. 2AFAI Signs Joint Venture Agreement With Jatro Greentech Inc. 3RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 2RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 3RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 4
... The world,s smallest chess board about the diameter ... were winners in this year,s design contest for, respectively, ... National Laboratories in mid May. The two winning ... facility, one of the most advanced in the world. ...
... Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer ... its AspirinWorks® Test June 17-19 at the Pri-Med New York ... Convention Center in New York, N.Y. , ... Corgenix representatives will be on-hand during the conference ...
... New data from a retrospective cohort study showed that up ... (GID) that can have a substantial adverse effect on major PD-related clinical ... Congress of Parkinson,s Disease and Movement Disorders in Buenos Aires, Argentina ... , , ...
Cached Biology Technology:Texas Tech, U of Utah win Sandia microdevice competition 2Texas Tech, U of Utah win Sandia microdevice competition 3Texas Tech, U of Utah win Sandia microdevice competition 4Corgenix to Exhibit AspirinWorks(R) Test at Pri-Med New York 2Corgenix to Exhibit AspirinWorks(R) Test at Pri-Med New York 3New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinson's Disease 2New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinson's Disease 3New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinson's Disease 4
(Date:9/16/2014)... have discovered the "molecular brakes" that time the generation ... mice. These "hair cells" translate sound waves into electrical ... interpreted as sounds. If the arrangement of the cells ... of the research will be published in The ... proteins Hey1 and Hey2 act as brakes to prevent ...
(Date:9/16/2014)... inherit certain traits from our parents that are pre-determined. ... play out by taking certain drugs or better yet, ... team of researchers at the Boston University School of ... research. , Epigenetics regulates gene expression in a ... which prevent permanent mutations or alterations within the gene ...
(Date:9/16/2014)... species has its own bacterial identity. That,s the conclusion ... institutions who studied the genetic fingerprints of bacteria on ... , "This study demonstrates for the first time that ... ecological strategies possess very different microbial communities on their ... postdoctoral researcher in the UO,s Institute of Ecology and ...
Breaking Biology News(10 mins):Hey1 and Hey2 ensure inner ear 'hair cells' are made at the right time, in the right place 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 3Microbiome research shows each tree species has a unique bacterial identity 2
... Future of the Nuclear Industry" will be the Plenary Session topic ... taking place June 28-July 1, 2010, at the Salt Palace Convention ... Chair of the Nuclear Regulatory Commission, will be the lead presenter ... Over 250 presentations between June 28 and July 1 will occur ...
... been established for more than 50 years as one ... termed bipolar disorder. However, scientists have never been ... new research from Cardiff University scientists suggests a possible ... better understanding of the illness and potentially more effective ...
... bacteria lead oil companies to change their methods of harvesting ... reducing the carbon dioxide that burning oil and gasoline discharges ... Larter, professor of geoscience and holder of the ... Calgary, was the keynote speaker today for the 2010 Goldschmidt ...
Cached Biology News:55th annual meeting of the Health Physics Society 2
...
...
... The pCITE-2a-c(+) vectors are designed for enhanced translation ... extracts, e.g. rabbit reticulocyte lysate. The maps for ... with the following exceptions: pCITE-2b(+) is a 3793 ... BstX I and Xcm I sites. Subtract 7 ...
...
Biology Products: